These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33140135)

  • 41. Fasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal type.
    Cai Q; Luo X; Liang Y; Rao H; Fang X; Jiang W; Lin T; Lin T; Huang H
    Br J Cancer; 2013 Feb; 108(2):380-6. PubMed ID: 23299534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma.
    Li N; Zhang L; Song HL; Zhang J; Weng HW; Zou LQ
    Tumour Biol; 2017 May; 39(5):1010428317705503. PubMed ID: 28475009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased body mass index is associated with improved overall survival in extranodal natural killer/T-cell lymphoma, nasal type.
    Li YJ; Yi PY; Li JW; Liu XL; Liu XY; Zhou F; OuYang Z; Sun ZY; Huang LJ; He JQ; Yao Y; Fan Z; Tang T; Jiang WQ
    Oncotarget; 2017 Jan; 8(3):4245-4256. PubMed ID: 28002803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of prognostic nutritional index on extranodal natural killer/T-cell lymphoma patients: A multicenter propensity score matched analysis of 1022 cases in Huaihai Lymphoma Working Group.
    Shen Z; Zhang S; Chen X; Zhang Q; Jiao Y; Shi Y; Zhang H; Ye J; Wang L; Zhu T; Miao Y; Wang L; Cai G; Sang W
    Hematol Oncol; 2023 Aug; 41(3):380-388. PubMed ID: 36680513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Clinical Features and Survival Outcome of 107 Newly Diagnosed Advanced Stage Extranodal NK/T-Cell Lymphoma Cases: A Triple-Center Study.
    Li J; Li J; Zhong M; Zhou H; Yu B
    Cancer Manag Res; 2021; 13():1541-1549. PubMed ID: 33623433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
    Li P; Jiang L; Zhang X; Liu J; Wang H
    BMC Cancer; 2014 Nov; 14():890. PubMed ID: 25429803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
    Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
    Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic indicators of survival in sinonasal extranodal natural killer/T-cell lymphoma.
    Varelas AN; Ganti A; Eggerstedt M; Tajudeen BA
    Laryngoscope; 2019 Dec; 129(12):2675-2680. PubMed ID: 30801751
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High IL-6 expression in the tumor microenvironment is associated with poor prognosis of patients with extranodal natural / killer T-cell lymphoma (ENKTL).
    Rong Q; Gao Y; Cai Q; Wang X; Bai B; Ping L; He H; Rao H; Zhang Y; Li Z; Cai Q; Jiang W; Huang H
    Expert Rev Anticancer Ther; 2021 Jan; 21(1):121-127. PubMed ID: 33397158
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma.
    Yhim HY; Kim JS; Mun YC; Moon JH; Chae YS; Park Y; Jo JC; Kim SJ; Yoon DH; Cheong JW; Kwak JY; Lee JJ; Kim WS; Suh C; Yang DH;
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1597-604. PubMed ID: 25963920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
    Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
    J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Red blood cell distribution width as a predictor of survival in nasal-type, extranodal natural killer/T-cell lymphoma.
    Luo H; Quan X; Song XY; Zhang L; Yin Y; He Q; Cai S; Li S; Zeng J; Zhang Q; Gao Y; Yu S
    Oncotarget; 2017 Nov; 8(54):92522-92535. PubMed ID: 29190934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic Nomogram for Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma Patients.
    Li K; Wang R; Huang S; Pan X; Chen H; Zhou L; Wei J; Wu C; Zhu X; Liang S; Qu S
    Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):e537-e543. PubMed ID: 30243570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A proposal for a prognostic index for non-nasal type natural killer/T cell lymphoma after asparaginase-based treatment.
    Chen Z; Fang X; Huang H; Wang Z; Hong H; Chen M; Ren Q; Yao Y; Zhang L; Tian Y; Lin S; Lin T
    Ann Hematol; 2020 Dec; 99(12):2811-2819. PubMed ID: 32975588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B virus infection correlates with poor prognosis of extranodal natural killer/T cell lymphoma.
    Wang L; Wu-Xiao ZJ; Chen XQ; Zhang YJ; Lu Y; Xia ZJ
    Leuk Lymphoma; 2015 Apr; 56(4):936-41. PubMed ID: 25110821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinicopathological analysis of immunohistochemical CD47 and signal-regulatory protein-α expression in Extranodal Natural killer/T-cell lymphoma.
    Tan Z; Zhang Q; Wang Y; Wang Y; Zhang S; Xing X; Liu H; Shen Z; Sang W
    Ann Hematol; 2024 Aug; 103(8):3033-3042. PubMed ID: 38886192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of Epstein-Barr virus DNA in NK/T-cell lymphoma: a meta-analysis.
    Fei Q; Tian XK; Wu J; Zhu HM; Wang Y; Peng FY; Zhang WJ; Yin L; He X
    Onco Targets Ther; 2018; 11():997-1004. PubMed ID: 29520150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.
    Huang Y; Rao H; Yan S; Wang F; Wu Q; Feng Y; Zhang Y
    Ann Hematol; 2017 Aug; 96(8):1331-1342. PubMed ID: 28550598
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type.
    Yao N; Hou Q; Liang Y; Cao X; Sun B; Wei L; Sun R; Cao J
    Cancer Biomark; 2024; 39(4):265-275. PubMed ID: 38108343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Derivation and validation of a nutrition-covered prognostic scoring system for extranodal NK/T-cell lymphoma.
    Lu T; Shi X; Ge X; Li Y; Cai Y; Chen X; Hu S; Ding M; Fang X; Liu F; Zhou X; Wang X
    Front Nutr; 2023; 10():1080181. PubMed ID: 37252237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.